Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials

BACKGROUND: This study assessed the immunogenicity of pegvaliase (recombinant Anabaena variabilis phenylalanine [Phe] ammonia lyase [PAL] conjugated with polyethylene glycol [PEG]) treatment in adults with phenylketonuria (PKU) and its impact on safety and efficacy. METHODS: Immunogenicity was asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Soumi, Lau, Kelly, Harding, Cary O., Shepherd, Gillian, Boyer, Ryan, Atkinson, John P., Knight, Vijaya, Olbertz, Joy, Larimore, Kevin, Gu, Zhonghu, Li, Mingjin, Rosen, Orli, Zoog, Stephen J., Weng, Haoling H., Schweighardt, Becky
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286649/
https://www.ncbi.nlm.nih.gov/pubmed/30366815
http://dx.doi.org/10.1016/j.ebiom.2018.10.038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286649/
https://www.ncbi.nlm.nih.gov/pubmed/30366815
http://dx.doi.org/10.1016/j.ebiom.2018.10.038

Ejemplares similares